Toggle navigation
Home
Search
Services
Blog
Contact
About
Pediatric Hydroxyurea Phase III Clinical Trial
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Complement regulatory proteins and autoimmune disease
Molecular organization of CNS synapses
Protein-RNA Recognition in Neurodegenerative Syndromes
Experimental Therapeutics Exploiting Folate Receptors
Effect of Tobacco Smoke on Leukocyte Adhesion in Vivo
Recently added grants:
Macrophage small RNA export to HDL protects against inflammation and atherosclerosis
Modification of HDL and Macrophage Function in Atherosclerosis
Synergistic Effects of Anxiety and Alcohol Use among Latinos and its Sociocultural Mechanisms
Decision Making on Continuous Scales in Aging and Alzheimers Disease
Imaging Tauopathy in the Dominanatly Inherited Alzheimer Network (DIAN)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB07151-17-0-1
Application #
7574820
Study Section
Project Start
2000-09-01
Project End
2009-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/ Duke University
$270,293
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
Thornburg, Courtney /
$292,009
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/
NIH 2007
N01 HL
/
Comments
Be the first to comment on this grant